Drug Quality Crisis: 94 Samples Found Substandard in August
In August, central and state drug laboratories identified 94 drug samples as 'not of standard quality.' The routine checks aim to safeguard public health, with three samples from Bihar flagged as spurious. Regulatory actions are underway to address the issue, ensuring unsafe drugs are withdrawn from the market.
- Country:
- India
In an alarming discovery, 94 drug samples were flagged as 'not of standard quality' by the central and state drugs laboratories in August, according to health ministry officials.
Three of these spurious samples originated from Bihar, produced illegally by an unauthorized manufacturer. This underscores the significance of stringent regulatory checks, especially those conducted by the Central Drugs Standard Control Organisation (CDSCO) on a monthly basis.
The ongoing investigations aim not only to penalize the offending manufacturers but also to strengthen the regulatory framework to prevent future occurrences. Officials emphasize that these failures were specific to the tested batches and do not reflect the overall quality of other market products.
ALSO READ
Prashant Kishor Alleges Widespread Corruption Among Bihar's NDA Leadership
Bihar's Strides in Empowering Women: A Model for Social Change
Bihar's Digital Defense: Unveiling New Cybercrime Combat Cell
Controversy in Bihar: Prashant Kishor Exposes Alleged Corruption
Tejashwi Yadav Champions New Politics with Focus on Development in Bihar
Google News